| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/14/2004 | US6790827 Bioconjugates and delivery of bioactive agents |
| 09/14/2004 | US6790825 Stimulating secretion of pancreatic juices |
| 09/14/2004 | US6790463 Peroxidation reaction products of an alkene, such as geraniol; penetrating solvent, such as dimithyl sulfoxide; a dye containing a chelated metal, such as hematoporphyrin; and an aromatic redox compound, such as benzoquinone. |
| 09/14/2004 | US6790458 Pharmaceutical compositions using semi-solid delivery vehicle |
| 09/14/2004 | US6790445 Preservatives for vaccines |
| 09/14/2004 | US6790439 Thrombopoietin compositions |
| 09/14/2004 | US6790437 Method of treating cancerous tumors with a dendritic-platinate drug delivery system |
| 09/14/2004 | CA2459869A1 A system for use by compounding pharmacists to produce hormone replacement medicine customized for each consumer |
| 09/14/2004 | CA2136438C Anthracycline conjugates, their preparation and their use as antitumor agents |
| 09/14/2004 | CA2073113C Conjugates |
| 09/12/2004 | CA2458761A1 Prosthesis with sustained release analgesic |
| 09/10/2004 | WO2004076658A1 Monoclonal antibody, gene encoding the same, hybridoma, medicinal composition and diagnostic reagent |
| 09/10/2004 | WO2004076644A2 A composition for delivering an agent to a target cell and uses thereof |
| 09/10/2004 | WO2004076621A2 Compositions of nucleic acids for treating and detecting influenza virus |
| 09/10/2004 | WO2004076602A1 Method of preventing lipids constituting lipid membrane from degradation and use thereof |
| 09/10/2004 | WO2004076561A1 Poloxamer emulsion preparations |
| 09/10/2004 | WO2004076557A1 Biodegradable polyacetals |
| 09/10/2004 | WO2004076474A2 Polyethylene glycol modified interferon compositions and methods of use thereof |
| 09/10/2004 | WO2004076471A1 Anti-influenza virus compound comprising biflavonoid-sialic acid glycoside |
| 09/10/2004 | WO2004076369A2 Antimicrobial active borosilicate glass |
| 09/10/2004 | WO2004075989A1 Fumed silica embolic compositions |
| 09/10/2004 | WO2004075923A2 Polymer-factor viii moiety conjugates |
| 09/10/2004 | WO2004075922A2 Compounds comprising at least one active substance and at least one carrier which are connected by a binding agent, uses thereof and said binding agents |
| 09/10/2004 | WO2004075921A1 Inclusion complex of artemisinin or derivates thereof with cyclodextrins |
| 09/10/2004 | WO2004075920A1 Sustained-release pharmaceutical composition for lung administration |
| 09/10/2004 | WO2004075919A2 Compounds for protein stabilization and methods for their use |
| 09/10/2004 | WO2004075918A1 Liquid formulations of tumor necrosis factor-binding proteins |
| 09/10/2004 | WO2004075913A1 Stabilized preparation containing protein |
| 09/10/2004 | WO2004075900A2 Pharmaceutical formulations comprising sodium laurylsulfate as bitterness masking agent |
| 09/10/2004 | WO2004075854A2 Microbicidal compositions and method of use |
| 09/10/2004 | WO2004075834A2 Stabilized pharmaceutical compositions of safingol and methods of using the same |
| 09/10/2004 | WO2004075824A2 Pharmaceutical compositions for nasal delivery |
| 09/10/2004 | WO2004075822A2 Pharmaceutical composition for transdermal or transmucosal administration |
| 09/10/2004 | WO2004075811A2 Subcutaneously-administered ganglioside-based vaccine compositions |
| 09/10/2004 | WO2004064850A8 Antiviral composition comprising a sulphated glucose polymer and a bacteriostatic agent |
| 09/10/2004 | WO2004062564A3 Sedative non-benzodiazepine formulations |
| 09/10/2004 | WO2004058803A3 Peptides that bind of the vegfr-2 |
| 09/10/2004 | WO2004050795A3 Antioxidant-functionalized polymers |
| 09/10/2004 | WO2004047799A3 Pellets containing non-aqueous fluids and the process for their preparation |
| 09/10/2004 | WO2004047795A3 Cutaneous application of flupirtine |
| 09/10/2004 | WO2004043357A3 Method of making, and the use of cytotoxic agents containing elemental selenium |
| 09/10/2004 | WO2004037208A3 Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin |
| 09/10/2004 | WO2004022128A3 Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
| 09/10/2004 | WO2003053169A8 Soft drink replacer |
| 09/10/2004 | WO2003003979A3 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
| 09/10/2004 | CA2788505A1 Polymer-factor viii moiety conjugates |
| 09/10/2004 | CA2517369A1 Polymer-factor viii moiety conjugates |
| 09/10/2004 | CA2517310A1 Stabilized protein-containing formulations_comprising a poloxamer |
| 09/10/2004 | CA2517104A1 Anti-influenza virus compounds comprising biflavonoid-sialic acid conjugates |
| 09/10/2004 | CA2517074A1 Nucleic acid molecules, polypeptides, antibodies and compositions containing same useful for treating and detecting influenza virus infection |
| 09/10/2004 | CA2516552A1 Polyethylene glycol modified interferon compositions and methods of use thereof |
| 09/10/2004 | CA2516459A1 Pharmaceutical compositions for nasal delivery |
| 09/10/2004 | CA2516399A1 Pharmaceutical compositions of safingol and methods of using the same |
| 09/10/2004 | CA2515539A1 Liquid formulations of tumor necrosis factor-binding proteins |
| 09/10/2004 | CA2515389A1 Monoclonal antibody and gene encoding the same, hybridoma, pharmaceutical compostion, and diagnostic reagent |
| 09/09/2004 | US20040176749 Insert for the treatment of dry eye |
| 09/09/2004 | US20040176576 Antibodies against cancer |
| 09/09/2004 | US20040176569 Regioselective liquid phase pegylation |
| 09/09/2004 | US20040176476 Pharmaceutical composition |
| 09/09/2004 | US20040176473 Methods for delivering compounds into a cell |
| 09/09/2004 | US20040176439 coadministration of agent which exhibits poor or inconsistent oral bioavailability (e.g., paclitaxel, docetaxel or etoposide), and an oral bioavailability-enhancing agent (e.g., cyclosporin A, cyclosporin D, cyclosporin F) |
| 09/09/2004 | US20040176359 Intranasal Benzodiazepine compositions |
| 09/09/2004 | US20040176357 Stable, amorphous , lyophilized, parenteral injections comprising olanzapine, solubilizer and stabilizer; bipolar, psychological and neurodegenerative disorders; anxiolytic agents;schizophrenia |
| 09/09/2004 | US20040176342 Fluticasone lotion having improved vasoconstrictor activity |
| 09/09/2004 | US20040176328 Encapsulated bioactive bisphosphonate such as alendronate including mono- or diglyceride of caproic or capric acid enhancer or surfactant comprising ethylene oxide-propylene oxide block copolymer |
| 09/09/2004 | US20040176321 9-Fluoro-6,7-dihydro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1H,5H-benzo[i,j]quinolizine-2-carboxylic acid derivatives; basic amino acid or cyclodextrin solubilizer; microbiocide injections |
| 09/09/2004 | US20040176319 Cellular uptake of bioactive agents |
| 09/09/2004 | US20040176318 Pretreating with lipophilic substituted saccharide |
| 09/09/2004 | US20040176312 Treatment of ungual and subungual diseases |
| 09/09/2004 | US20040176299 Combination of pancreatic cell surface marker binding agent, polypeptide translocation transfer element and enzymatic secretion inhibitor |
| 09/09/2004 | US20040176281 Pharmaceutical carriers comprised of at least mono- or oligosaccharide and lipidic moiety; intestinal absorption |
| 09/09/2004 | US20040176270 Use of isocyanate linkers to make hydrolyzable active agent biopolymer conjugates |
| 09/09/2004 | US20040175703 to be administered by inhalation, infusion, injection, or orally relates to double-stranded ribonucleic acid (dsRNA), and its use in mediating RNA interference in vitro and in vivo; genetic engineering |
| 09/09/2004 | US20040175437 preventing and treating certain inflammatory diseases, degenerative diseases and viral diseases in mammals |
| 09/09/2004 | US20040175435 preservative that do not become complexed with, or to a lesser degree than does benzalkonium chloride, cyclodextrin and are not rendered ineffective; chlorite or sorbic acid preservative |
| 09/09/2004 | US20040175433 using a viscous rather than a liquid footbath performs much better in preventing and combating hoof diseases; active ingredient and a colloid former |
| 09/09/2004 | US20040175424 Medicine based on anti-hyperglycaemic microcapsules with prolonged release and method for preparing same |
| 09/09/2004 | US20040175422 excellent storage stability and little tendency to change the release rate of the pharmacologically active substance even after long-term storage; matrix comprising low-melting-point substance and pH-independent water-insoluble polymer |
| 09/09/2004 | US20040175420 at least one non-ionic or zwitterionic surfactant and dispersant; improves the efficacy and/or potency of the lipase inhibitor; inter-subject variability in efficacy and/or potency is reduced, as well as the frequency and intensity of side effects |
| 09/09/2004 | US20040175419 controlling crystallization parameters of active ingredient to achieve increased compactability; compacting the active ingredient into a tablet |
| 09/09/2004 | US20040175418 Teste masking pharmaceutical composition |
| 09/09/2004 | US20040175416 Pharmaceutical composition for transdermal or transmucous administration |
| 09/09/2004 | US20040175415 Formulations and methods of delivery of intact tocopheryl succinate to humans |
| 09/09/2004 | US20040175407 Microorganism coating components, coatings, and coated surfaces |
| 09/09/2004 | US20040175402 Formulation |
| 09/09/2004 | US20040175387 O,O'-amidomalonate and N,O-amidomalonate platinum complexes |
| 09/09/2004 | US20040175374 Therapeutic platelets and methods |
| 09/09/2004 | US20040175363 Defective recombinant adenovirus; treatment of neurodenerative, cardiovascular, brain, genetic, nervous system and respiratory system disorders; Alzheimer's, Parkinson's, amyotrophic lateral sclerosis (ALS), atherosclerosis, and/or trisomy 2; adult respiratory distress syndrome; anticarcinogenic agents |
| 09/09/2004 | US20040175353 Cyanoacrylate compositions for prophylactic or therapeutic treatment of diseases manifesting themselves in and/or damage cutaneous tissue |
| 09/09/2004 | US20040175348 formed by spray-drying a solution of an edible organic acid wherein chitosan is dissolved; storage stability |
| 09/09/2004 | US20040175342 Process of making and using composition containing oxidation-sensitive hydrophilic active principle and maleic anhydride copolymer |
| 09/09/2004 | US20040175335 Sunscreen composition |
| 09/09/2004 | US20040173224 Nicotine salts having improved taste, process for their preparation and their use |
| 09/09/2004 | DE10309005A1 New conjugates comprising a dipeptidyl peptidase inhibitor linked to a neural endopeptidase inhibitor, e.g. useful for treating diabetes, obesity, growth hormone deficiency, immunosuppression, HIV infection |
| 09/09/2004 | DE10304988A1 Transdermales Therapeutisches System mit verbessertem Hautklebeverhalten The transdermal therapeutic system with improved skin adhesive behavior |
| 09/09/2004 | DE10107663B4 Testosteronhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung Testosterone-containing transdermal therapeutic system, process for its preparation and its use |
| 09/09/2004 | DE10004790B4 Method for producing sewn or embroidered three-dimensional textile structure utilized for e.g. table cloth, involves connecting points on lattice structure with threads to form thread arrangement under which lattice structure is not visible |
| 09/08/2004 | EP1454950A1 Pullulan-containing powder, process for producing the same and use thereof |
| 09/08/2004 | EP1454640A2 Formulations of hyaluronic acid for delivery of osteogenic proteins |
| 09/08/2004 | EP1454635A1 Tasteless, directly compressible, fast-dissolving complexes and pharmaceutical formulations thereof |